Chris Schelling
2018
In 2018, Chris Schelling earned a total compensation of $550K as President and Chief Executive Officer at Opexa Therapeutics, a 6% decrease compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Salary | $400,000 |
| Total | $550,000 |
Schelling received $400K in salary, accounting for 73% of the total pay in 2018.
Schelling also received $150K in bonus.
Rankings
In 2018, Chris Schelling's compensation ranked 11,565th out of 14,244 executives tracked by ExecPay. In other words, Schelling earned more than 18.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,565 out of 14,244 | 19th |
Division Manufacturing | 4,667 out of 5,759 | 19th |
Major group Chemicals And Allied Products | 1,767 out of 2,122 | 17th |
Industry group Drugs | 1,503 out of 1,811 | 17th |
Industry Pharmaceutical Preparations | 1,154 out of 1,385 | 17th |
Source: SEC filing on April 12, 2019.
Schelling's colleagues
We found two more compensation records of executives who worked with Chris Schelling at Opexa Therapeutics in 2018.
News
Opexa Therapeutics CEO Chris Schelling's 2022 pay jumps 51% to $834K
April 14, 2023
Opexa Therapeutics Chief Business Officer Jefferson Davis receives $635K in 2021
April 15, 2022
Opexa Therapeutics CEO Chris Schelling's 2020 pay falls 54% to $676K
April 16, 2021
Opexa Therapeutics CEO Chris Schelling's 2019 pay jumps 167% to $1.5M
October 14, 2020
Opexa Therapeutics CEO Chris Schelling's 2018 pay slips 6% to $550K
April 12, 2019